• Nitric Oxide-Driven Nanomotors Enhance Immunotherapy for GBM

  2026-06-29

  This study introduces a nitric oxide-driven chemotactic nanomotor designed to overcome targeting and immune activation barriers in glioblastoma immunotherapy. By leveraging the tumor microenvironment's unique ROS and iNOS gradients, these nanomotors achieve precise delivery and robust immune modulation, demonstrating promising results for preventing tumor recurrence.

• Triamcinolone: Technical Guide for Synthetic Glucocorticoid

  2026-06-28

  Triamcinolone (SKU B1859) addresses the need for a high-purity, synthetic glucocorticoid agonist in controlled studies of glucocorticoid receptor signaling, anti-inflammatory mechanisms, and immunosuppression pathways. It is intended exclusively for in vitro research and should not be used for diagnostic or therapeutic applications.

• Irinotecan (CPT-11): Mechanistic Insights and Toxicity Mitig

  2026-06-27

  Explore the advanced mechanistic understanding of Irinotecan (CPT-11) in colorectal cancer research, with a focus on DNA damage, apoptosis, and strategies for mitigating chemotherapy-induced toxicity. Discover deeper scientific context and practical guidance for assay design.

• ERAD-Hijacking ERADECs Enable Potent Degradation of TM Prote

  2026-06-26

  Song et al. present ERAD-engaging chimeras (ERADECs), a small-molecule platform that enables highly efficient and selective degradation of transmembrane (TM) proteins by hijacking the ER-associated degradation pathway. This innovation addresses major barriers in targeted protein degradation and offers new strategies for drug discovery targeting otherwise intractable membrane proteins.

• Structural and Functional Divergence of Human PSS2 in Lipid

  2026-06-26

  This study provides a high-resolution cryo-EM structure of human phosphatidylserine synthase 2 (PSS2), revealing its unique substrate specificity and regulatory role in SREBP pathways. The findings highlight how homologous lipid enzymes can exert opposing effects on cellular lipid homeostasis, with implications for research on membrane biology and metabolic regulation.

• Triamcinolone: Technical Parameters for Glucocorticoid Resea

  2026-06-25

  Triamcinolone is a synthetic glucocorticoid agonist designed to support controlled studies of glucocorticoid receptor signaling, inflammation, and immunosuppression in laboratory settings. It is not intended for diagnostic or clinical applications and requires careful attention to solubility and storage to ensure consistent results.

• ERAD-Hijacking Chimeras Enable Selective TM Protein Degradat

  2026-06-25

  Song et al. introduce ERAD-engaging chimeras (ERADECs), a small-molecule strategy that enables highly efficient, targeted degradation of transmembrane proteins by hijacking the ER-associated degradation (ERAD) pathway. This platform overcomes major barriers in targeted protein degradation and demonstrates substantial tumor suppression efficacy, offering new avenues for membrane protein research and drug discovery.

• EZ Cap EGFP mRNA 5-moUTP: Optimizing Fluorescent Assays & De

  2026-06-24

  EZ Cap™ EGFP mRNA (5-moUTP) unlocks reliable, immune-evasive fluorescent protein expression for gene regulation and imaging, featuring advanced Cap 1 capping and 5-methoxyuridine modification. This guide translates state-of-the-art delivery and workflow insights into actionable protocols and troubleshooting strategies for high-sensitivity mRNA applications.

• SGI-1027-Induced Apoptosis in Huh7 Hepatocellular Carcinoma

  2026-06-23

  This study demonstrates that the DNA methyltransferase inhibitor SGI-1027 induces apoptosis in Huh7 human hepatocellular carcinoma cells via a mitochondrial-mediated pathway, independent of cell cycle arrest. The findings advance understanding of non-nucleoside epigenetic modulators as potential anticancer agents, with practical implications for designing targeted cancer epigenetics experiments.

• Nutlin-3a and the Future of MDM2 Inhibition in Translational

  2026-06-23

  Explore the mechanistic, experimental, and clinical potential of Nutlin-3a as a transformative MDM2 inhibitor for activating the p53 pathway, with strategic insights for translational researchers. Integrating new perspectives from glioblastoma lipid metabolism and ferroptosis, this article offers advanced guidance for leveraging Nutlin-3a in next-generation cancer research.

• ERAD-Hijacking Chimeras Enable Degradation of TM Proteins

  2026-06-22

  Song et al. introduce ERAD-engaging chimeras (ERADECs), a small-molecule platform that co-opts the ER-associated degradation (ERAD) pathway to selectively degrade transmembrane (TM) proteins. This work overcomes major challenges in targeted protein degradation technology and demonstrates high efficacy against therapeutically relevant targets, expanding opportunities in membrane protein research and drug discovery.

• Dynasore in Mechanistic Endocytosis Assays: Insights and Pro

  2026-06-22

  Explore how Dynasore, a leading dynamin GTPase inhibitor, offers new mechanistic clarity for endocytosis research. This article delivers advanced protocol guidance and uniquely analyzes recent nanoparticle uptake findings for practical assay design.

• Asunaprevir (BMS-650032): Precision HCV RNA Replication Inhi

  2026-06-21

  Asunaprevir (BMS-650032) empowers hepatitis C research with nanomolar potency and broad genotype coverage, enabling robust, reproducible inhibition of HCV RNA replication in diverse cell models. Discover protocol optimizations, troubleshooting strategies, and unique advantages for translational virology workflows.

• (S)-Mephenytoin in CYP2C19 Research: Bridging Kinetics and O

  2026-06-20

  (S)-Mephenytoin is a gold-standard CYP2C19 substrate vital for modern pharmacokinetic studies. This article uniquely explores its kinetic properties, practical assay integration, and the transformative impact of hiPSC-derived intestinal organoids.

• Translating DNA Damage Insights: γH2AX Detection for Precisi

  2026-06-19

  Explore the mechanistic power and strategic deployment of the γH2AX DNA Damage Detection Kit (Mouse mAb/Red) in translational research. Analyze how γ-H2AX immunofluorescence bridges fundamental DNA repair mechanisms with high-content genotoxicity assays, radiotherapy innovation, and clinical application. Learn how APExBIO’s kit, referenced in radiotherapy enhancement studies, enables rigorous, reproducible DNA double-strand break detection—shaping the future of precision medicine.

450 records 13/30 page Previous Next First page 上5页 1112131415 下5页 Last page